# A Study Comparing Three Strategies to Switch Patients With Schizophrenia or Schizoaffective Disorder to Risperidone After Unsuccessful Treatment With Olanzapine.

> **NCT00378183** · PHASE4 · COMPLETED · sponsor: **Janssen, LP** · enrollment: 120 (actual)

## Conditions studied

- Schizoaffective Disorder
- Schizophrenia

## Interventions

- **DRUG:** risperidone

## Key facts

- **NCT ID:** NCT00378183
- **Lead sponsor:** Janssen, LP
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-02
- **Primary completion:** —
- **Final completion:** 2002-05
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2010-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00378183

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00378183, "A Study Comparing Three Strategies to Switch Patients With Schizophrenia or Schizoaffective Disorder to Risperidone After Unsuccessful Treatment With Olanzapine.". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00378183. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*